Impact of the fetal fibronectin assay on admissions for preterm labor

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 3 I, 1999, Pages 581-586

  Joffe, G M ^a   Jacques, D ^a   Bernis Heys, R ^a   Burton, R ^a   Sicram, B ^a   Shelburne, P ^a  

^a LOVELACE MEDICAL CENTER   (United States)

Author keywords

Fetal fibronectin assay; Lower genital tract infection; Preterm delivery; Preterm labor

Indexed keywords

CORTICOSTEROID; FIBRONECTIN; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; FEMALE; GENITAL TRACT INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0033020750     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70258-9     Document Type: Article

References (13)

1. AA Ortiz 1995 State of New Mexico selected health statistics 1997 Department of Health/Public Health Division, Office of Information Management, New Mexico Vital Records and Health Statistics Sante Fe (NM) 29
2. GM Joffe R Cementos D Alberton L Chiton The effect of a comprehensive prematurity prevention program on the number of admissions to the newborn intensive care unit J Perinatol 15 1995 305 309
3. CJ Lacewood AE Senyei R Dische Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery N Engl J Med 325 1991 669 674
4. MP Nageotte D Casal AE Senyei Fetal fibronectin in patients at increased risk for premature birth Am J Obstet Gynecol 170 1994 20 25
5. JD Iams D Casal JA McGregor Fetal fibronectin improves the accuracy of diagnosis of preterm labor Am J Obstet Gynecol 173 1995 141 145
6. RL Goldenberg BM Mercer PL Meis The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth Obstet Gynecol 87 1996 643 648
7. AM Peaceman WW Andrews JM Thorp Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial Am J Obstet Gynecol 177 1997 13 18
8. H Matsuura SI Hakomori The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma Proc Natl Acad Sci U S A 82 1985 6517 6521
9. DA Eschenbach Bacterial vaginosis and anaerobes in obstetric-gynecologic infection Clin Infect Dis 16 1993 S282 S287
10. A Stein L Boubli B Blanc D Raoul Genital mycoplasmas in placental infections Infect Dis Obstet Gynecol 1 1994 275 281
11. MA Oleen-Burkey SL Hillier Pregnancy complications associated with bacterial vaginosis and their estimated costs Infect Dis Obstet Gynecol 3 1995 149 157
12. JC Hauth RL Goldenberg WW Andrews Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis N Engl J Med 333 1995 1732 1736
13. RL Goldenberg E Thom AH Moawad The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection Obstet Gynecol 87 1996 656 660